Hydroxyurea Exposure in Lactation: a Pharmacokinetics Study (HELPS)
Authors:
- 1 July 2020
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 222, 236-239
Abstract
No abstract availableKeywords
Funding Information
- Cincinnati Children’s Research Foundation
This publication has 19 references indexed in Scilit:
- Maternal mortality among women with sickle-cell disease in France, 1996–2009European Journal of Obstetrics & Gynecology and Reproductive Biology, 2015
- Variation of Milk Intake over Time: Clinical and Pharmacokinetic ImplicationsBreastfeeding Medicine, 2015
- Adverse maternal and perinatal outcomes in pregnant women with sickle cell disease: systematic review and meta-analysisBlood, 2015
- Management of Sickle Cell DiseaseJAMA, 2014
- Clinical complications in pregnant women with sickle cell disease: prospective study of factors predicting maternal death or near missRevista Brasileira de Ginecologia e Obstetrícia, 2014
- Reasons for Earlier Than Desired Cessation of BreastfeedingPediatrics, 2013
- Breastfeeding and the Use of Human MilkPediatrics, 2012
- Pharmacokinetics, pharmacodynamics, and pharmacogenetics of hydroxyurea treatment for children with sickle cell anemiaBlood, 2011
- Excess Risk of Maternal Death from Sickle Cell Disease in Jamaica: 1998–2007PLOS ONE, 2011
- Drugs in Human MilkClinical Pharmacokinetics, 1988